Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
BioLife Solutions, Inc. (BLFS) had Cost of Goods Sold of $8.15M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$23.94M |
|
$-0.45M |
|
|
Cost of Goods Sold |
$8.15M |
$15.79M |
|
$25.16M |
|
$-1.22M |
|
$0.78M |
|
$-0.43M |
|
$-0.43M |
|
$-0.45M |
|
$-0.45M |
|
$-0.45M |
|
$-0.45M |
|
$-1.22M |
|
$0.17M |
|
47.13M |
|
47.13M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$131.13M |
|
$6.61M |
|
$264.01M |
|
$395.14M |
|
$27.72M |
|
$2.50M |
|
$14.79M |
|
$42.52M |
|
$352.62M |
|
$131.46M |
|
$352.62M |
|
47.55M |
|
| Cash Flow Statement Financials | |
$1.73M |
|
$-27.18M |
|
$-2.99M |
|
$95.39M |
|
$66.94M |
|
$-28.44M |
|
$4.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.73 |
|
-- |
|
-- |
|
0.01 |
|
0.04 |
|
65.94% |
|
-5.09% |
|
-5.09% |
|
-- |
|
-1.81% |
|
-1.87% |
|
$1.55M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.30 |
|
2.61 |
|
34.46 |
|
-0.13% |
|
-0.34% |
|
-0.11% |
|
-0.13% |
|
$7.42 |
|
$0.03 |
|
$0.04 |
|